A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectru... de réir Farhad Motavalli Khiavi, Arash Arashkia, Majid Golkar, Maryam Nasimi, Farzin Roohvand, Kayhan Azadmanesh

Faigh an téacs iomlán

Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies de réir Farhad Motavalli Khiavi, Arash Arashkia, Maryam Nasimi, Mehdi Mahdavi, Majid Golkar, Farzin Roohvand, Kayhan Azadmanesh

Faigh an téacs iomlán

Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis de réir Seyed Pooria Tadayon Nabavi, Mohsen Chamanara, Arasb Dabbagh Moghaddam, Mahdi Ghorbani, Reza Heidari, Mehdi Shakouri Khomartash, Javad Behroozi, Farhad Motavalli, Ali Shakerimoghaddam

Faigh an téacs iomlán

Hurdles to breakthrough in CAR T cell therapy of solid tumors de réir Faroogh Marofi, Harun Achmad, Dmitry Bokov, Walid Kamal Abdelbasset, Zeid Alsadoon, Supat Chupradit, Wanich Suksatan, Siavash Shariatzadeh, Zahra Hasanpoor, Mahboubeh Yazdanifar, Navid Shomali, Farhad Motavalli Khiavi

Faigh an téacs iomlán

Effect of Dextrose Prolotherapy, Platelet Rich Plasma and Autologous Conditioned Serum on Knee Osteoarthritis: A Randomized Clinical Trial de réir Alireza Pishgahi, Rozita Abolhasan, Seyed Kazem Shakouri, Mohammad Sadegh Soltani-Zangbar, Shahla Dareshiri, Sepideh Ranjbar Kiyakalayeh, Amirghasem Khoeilar, Majid Zamani, Farhad Motavalli Khiavi, Behzad Pourabbas Kheiraddin, Amir Mehdizadeh, Mehdi Yousefi

Faigh an téacs iomlán

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism de réir Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, Denis Kaigorodov, Alexander Markov, Alexei Valerievich Yumashev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Rebar N. Mohammed, Mostafa Jarahian, Roza Motavalli, Farhad Motavalli Khiavi

Faigh an téacs iomlán

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy de réir Faroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Thangavelu, Aleksey Dorofeev, Favian Bayas-Morejón, Naghmeh Shirafkan, Navid Shomali, Max Stanley Chartrand, Mostafa Jarahian, Ghasem Vahedi, Rebar N. Mohammed, Somayeh Shahrokh, Morteza Akbari, Farhad Motavalli Khiavi

Faigh an téacs iomlán

A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies de réir Ehsan Razeghian, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, Zhanna R. Gardanova, Walid Kamal Abdelbasset, Surendar Aravindhan, Dmitry O. Bokov, Wanich Suksatan, Pooria Nakhaei, Siavash Shariatzadeh, Faroogh Marofi, Mahboubeh Yazdanifar, Somayeh Shamlou, Roza Motavalli, Farhad Motavalli Khiavi

Faigh an téacs iomlán

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies de réir Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, Wanich Suksatan, Moaed E. Al-Gazally, Walid Kamal Abdelbasset, Lakshmi Thangavelu, Alexei Valerievich Yumashev, Ali Hassanzadeh, Mahboubeh Yazdanifar, Roza Motavalli, Yashwant Pathak, Adel Naimi, Behzad Baradaran, Marzieh Nikoo, Farhad Motavalli Khiavi

Faigh an téacs iomlán